In rapidly expanding global biopharmaceutical market, the growing demand for drug development highlights the need for effective assessment tools in selecting biologic compounds. Samsung Biologics addresses this challenge with its advanced development platform, DEVELOPICK™, offering cutting-edge technology and an innovative approach from the early stages.

In this webinar, we explore how DEVELOPICK™ systematically screens molecules, identifying candidates with the best potential for progression to Investigational New Drug (IND) and Biological License Application (BLA).

In this webinar you’ll learn:

• Learn how development platform help streamline development time and cost
• Understand the rationale behind using DEVELOPICK™ in the workflow process
• How DEVELOPICK™ ensures greater certainty during DSP and formulation development

• Biopharma/Biomedical researcher
• Cell line development
• Quality Assurance/Operations
• Research and Development